Inviting patients to undergo combined Helicobacter pylori stool antigen testing with fecal immunochemical testing (FIT) yielded superior cost-effectiveness compared with FIT alone ...
Each unit of cost invested in Helicobacter pylori screening can generate approximately a fivefold return in gastric cancer ...